Request Deal Involvement

SAB Biotherapeutics went public via a SPAC merger with Big Cypress Acquisition in a c.$325m deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Lazard

financial advisors

Lazard

Stradling Yocca Carlson & Rauth

legal advisors

Stradling Yocca Carlson & Rauth

BLL Partners

pr advisors

BLL Partners

Chardan

financial advisors

Chardan

Brookline Capital

financial advisors

Brookline Capital

Dentons

legal advisors

Dentons

Ladenburg Thalmann

financial advisors

Ladenburg Thalmann

or

Principals

SAB BIOTHERAPEUTICS INC

target

SAB BIOTHERAPEUTICS INC

BIG CYPRESS ACQUISITION CORP

bidder

BIG CYPRESS ACQUISITION CORP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite